An expert conversation with Navitas SMEs Bob Chastain & Dave Maslow

Discover how clean, aligned, analysis-ready data fuels every successful clinical trial.
In this episode of our “Ask Your Biostatistician” series, Bob Chastain (Biostatistics SME) and Dave Maslow (Clinical Data Management SME) share real-world insights on why clinical data reconciliation is one of the most critical drivers of trial quality, timelines and regulatory confidence.

This video gives you a crisp, high-value overview of why data reconciliation in clinical trials shapes every major trial outcome.

Robert (Bob) Chastain Biostatistics SME Navitas Life Sciences	Dave Maslow Clinical Data Management SME Navitas Life Sciences

What You Will Learn

While the conversation is best experienced firsthand, the video explores:

• How EDC and external data matching supports clean, trustworthy datasets
• The connection between clinical data quality and statistical decision-making
• The real operational impact of unresolved discrepancies
• Why reconciliation is not a “late-stage task” but a continuous discipline
• How strong CDM–Biostats collaboration enables faster, smoother submissions
• How technology, automation, and AI in clinical data management are changing the landscape

Every insight comes directly from experts who deal with real study data every day.

Navitas Life Sciences delivers a unified model across clinical data management services, biostatistics and statistical programming, ensuring that reconciliation is embedded into the full data lifecycle.

Our authority in data science was recognized when Navitas was named a Major Contender in the Everest Group 2025 CDM Operations Assessment.

Fill the form to watch the full video.

© 2025 Navitas Life Sciences | Privacy Policy